住院患者的血糖管理

参考文献

关键文献

American Diabetes Association. Standards of medical care in diabetes - 2021. Diabetes Care. 2021;44(suppl 1):S1-S232.全文

Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69.全文  摘要

Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188.全文  摘要

Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.全文  摘要

Umpierrez G, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007 Sep;30(9):2181-6.全文  摘要

参考文献

1. American Diabetes Association. Standards of medical care in diabetes - 2021. Diabetes Care. 2021;44(suppl 1):S1-S232.全文

2. Diabetes Canada (Canadian Diabetes Association). Clinical practice guidelines for the prevention and management of diabetes in Canada. 2018 [internet publication].全文

3. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002 Mar;87(3):978-82.全文  摘要

4. Fonseca V. Newly diagnosed diabetes/hyperglycemia in hospitals: what should we do? Endocr Pract. 2006 Jul-Aug;12 Suppl 3:108-11. 摘要

5. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000;29:745-770. 摘要

6. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047. 摘要

7. Inzucchi SE. Clinical practice: management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355:1903-1911. 摘要

8. Pasquel FJ, Smiley D, Spiegelman R, et al. Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition. Hosp Pract (Minneap). 2011;39:81-88. 摘要

9. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006 Jul-Aug;12(4):458-68.全文  摘要

10. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69.全文  摘要

11. Fonseca V. Clinical diabetes: translating research into practice. Philadelphia, PA: Elsevier Health Sciences; 2006.

12. Kornum JB, Thomsen RW, Riis A, et al. Diabetes, glycemic control, and risk of hospitalization with pneumonia. Diabetes Care. 2008 Aug;31(8):1541-5.全文  摘要

13. Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013 Apr;345(4):274-7. 摘要

14. Farrokhi F, Klindukhova O, Chandra P, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012 Sep 1;6(5):1022-9.全文  摘要

15. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188.全文  摘要

16. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67.全文  摘要

17. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010 Mar;137(3):544-51.全文  摘要

18. Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.全文  摘要

19. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009 Oct;35(10):1738-48. 摘要

20. van Kuijk JP, Schouten O, Flu WJ, et al. Perioperative blood glucose monitoring and control in major vascular surgery patients. Eur J Vasc Endovasc Surg. 2009 Nov;38(5):627-34. 摘要

21. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008 Aug 27;300(8):933-44. 摘要

22. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008 Mar 25;117(12):1610-9.全文  摘要

23. Inzucchi SE, Siegel MD. Glucose control in the ICU: how tight is too tight? New Engl J Med. 2009 Mar 26;360(13):1346-9. 摘要

24. Moghissi ES. Addressing hyperglycemia from hospital admission to discharge. Curr Med Res Opin. 2010 Mar;26(3):589-98. 摘要

25. Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011 Feb 15;154(4):260-7. 摘要

26. Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011 Feb 15;154(4):268-82. 摘要

27. Qaseem A, Chou R, Humphrey LL, et al. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual. 2014 Mar-Apr;29(2):95-8. 摘要

28. Kao LS, Meeks D, Moyer VA, et al. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009;(3):CD006806.全文  摘要

29. Liu Y, Yang YM, Zhu J, et al. Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol. 2011 Nov 10;10:98.全文  摘要

30. Vergès B, Avignon A, Bonnet F, et al; Diabetes and Cardiovascular Disease Study Group of the Société Francophone du Diabète (SFD), Société Française de Cardiologie (SFC). Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. Diabetes Metab. 2012 Apr;38(2):113-27. 摘要

31. Bielen I, Sruk A, Zalac D. Specificity of hyperglycemia treatment in acute stroke patients. Acta Med Croatica. 2008 Jul;62(3):273-80. 摘要

32. Ooi YC, Dagi TF, Maltenfort M, et al. Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery. 2012 Sep;71(3):692-702. 摘要

33. Gilo Arrojo F, Herrera Muñoz A, Anciones Rodríguez B. Recommendations for an adequate glycemic control during hospitalization after a stroke episode [in Spanish]. Avances en Diabetologia. 2010;26:408-412.全文

34. Ellger B, Westphal M, Stubbe HD, et al. Glycemic control in sepsis and septic shock: friend or foe? [in German]. Anaesthesist. 2008 Jan;57(1):43-8. 摘要

35. Umpierrez G, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007 Sep;30(9):2181-6.全文  摘要

36. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011 Feb;34(2):256-61.全文  摘要

37. Pasquel FJ, Lansang MC, Khowaja A, et al. A randomized controlled trial comparing Glargine U300 and Glargine U100 for the inpatient management of medicine and surgery patients with type 2 diabetes: Glargine U300 hospital trial. Diabetes Care. 2020 Jun;43(6):1242-1248.全文  摘要

38. Suzuki J, Yamakawa T, Oba M, et al. Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study. Endocr J. 2019 Nov 28;66(11):971-982.全文  摘要

39. Umpierrez GE, Smiley D, Hermayer K, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013 Aug;36(8):2169-74. 摘要

40. Vellanki P, Bean R, Oyedokun FA, et al. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes. Diabetes Care. 2015 Apr;38(4):568-74.全文  摘要

41. Svensson AM, McGuire DK, Abrahamsson P, et al. Association between hyper- and hypoglycemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005 Jul;26(13):1255-61. 摘要

42. Dumont C, Bourguignon C. Effect of a computerized insulin dose calculator on the process of glycemic control. Am J Crit Care. 2012 Mar;21(2):106-15.全文  摘要

43. Steil GM, Langer M, Jaeger K, et al. Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control. Pediatr Crit Care Med. 2011 Nov;12(6):643-8. 摘要

44. Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011 May 1;5(3):755-67.全文  摘要

45. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004 Feb;27(2):461-7.全文  摘要

46. Adams G, Hunter J, Langley J, et al. Is nurse-managed blood glucose control in critical care as safe and effective as the traditional sliding scale method? Intensive Crit Care Nurs. 2009 Dec;25(6):294-305. 摘要

47. Pinelli NR, Jones MC, Monday LM, et al. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients. Ann Pharmacother. 2012 Jan;46(1):124-9. 摘要

48. Thiruvenkatarajan V, Meyer EJ, Nanjappa N, et al. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019 Jul;123(1):27-36.全文  摘要

49. Pasquel FJ, Gianchandani R, Rubin DJ, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017 Feb;5(2):125-133.全文  摘要

50. Garg R, Schuman B, Hurwitz S, et al. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients. BMJ Open Diabetes Res Care. 2017;5(1):e000394.全文  摘要

51. Vellanki P, Rasouli N, Baldwin D, et al. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 Apr;21(4):837-843.全文  摘要

52. The Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting. 2012 [internet publication].全文

53. NHS Diabetes. The hospital management of hypoglycaemia in adults with diabetes mellitus. September 2013 [internet publication].全文

54. Agus MS, Steil GM, Wypij D, et al; SPECS Study Investigators. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012 Sep 27;367(13):1208-19.全文  摘要

55. Agus MS, Wypij D, Hirshberg EL, et al. Tight glycemic control in critically ill children. N Engl J Med. 2017 Feb 23;376(8):729-41. 摘要

56. Rickels MR, Ruedy KJ, Foster NC, et al. Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study. Diabetes Care. 2016 Feb;39(2):264-70.全文  摘要

57. Christiansen MP, Cummins MJ, Presteelski SJ, et al. A phase 3 comparison of a novel liquid glucagon autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia. Diabetes 2018 Jul; 67(Supplement 1).全文

58. Singh LG, Satyarengga M, Marcano I, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: The glucose telemetry system, a randomized clinical trial. Diabetes Care. 2020 Nov;43(11):2736-2743.全文  摘要

内容使用需遵循免责声明